BioCryst Pharmaceuticals (BCRX) Earnings Date & Reports

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

BCRX is expected to report earnings to fall 104.33% to 12 cents per share on July 30

BioCryst Pharmaceuticals BCRX Stock Earnings Reports

Q2'26

Est.

$0.13

Q1'26

Missed

by $3.03

Q4'25

Beat

by $1.08

Q3'25

Beat

by $0.11

Q2'25

Beat

by $0.14

The last earnings report on May 06 showed earnings per share of -298 cents, missing the estimate of 5 cents. With 1.91M shares outstanding, the current market capitalization sits at 2.32B.

View a ticker or compare two or three

Compare

BCRX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for BCRX